Related Experiment Video
Updated: Jul 2, 2025

09:36
Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
2.3K
Factors associated with D-lactic acidosis in pediatric intestinal failure: A case-control study
Emily Nes1,2, Jamie Knell1,2, Gregory Keefe1,2
1Center for Advanced Intestinal Rehabilitation, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Journal of Pediatric Gastroenterology and Nutrition
|February 20, 2024
Summary
D-lactic acidosis (DLA) is a serious complication in children with intestinal failure and short bowel syndrome. Midgut volvulus, intestinal lengthening, and anion gap acidosis are key risk factors for DLA.
Area of Science:
- Pediatric Gastroenterology
- Metabolic Disorders
- Intestinal Failure Management
Background:
- D-lactic acidosis (DLA) is a severe complication in pediatric patients with intestinal failure (IF) due to short bowel syndrome (SBS).
- Bacterial metabolism of malabsorbed carbohydrates in the intestine produces D-lactate, potentially causing metabolic acidosis and neurological symptoms.
Purpose of the Study:
- To identify risk factors and clinical characteristics associated with D-lactic acidosis in children with short bowel syndrome.
- To improve the monitoring and diagnosis of DLA in pediatric patients with IF.
Main Methods:
- Retrospective chart review of children (≤18 years) with SBS.
- Inclusion criteria included unexplained metabolic acidosis, neurological symptoms, or suspected DLA.
- Cases defined by serum D-lactate >0.25 mmol/L; controls ≤0.25 mmol/L.
Main Results:
- Forty-six children (23 cases, 23 controls) were analyzed; median age 3.16 years, median residual bowel length 40 cm.
- Cases showed significantly lower bicarbonate and higher anion gap compared to controls.
- Multivariable analysis identified midgut volvulus (aOR=17.1), history of intestinal lengthening, and anion gap as independent risk factors for DLA.
Conclusions:
- DLA is a significant complication in pediatric IF patients with SBS.
- Close monitoring for DLA is crucial in IF patients with a history of midgut volvulus, intestinal lengthening procedures, or anion gap acidosis.

